Abivax (ABVX) Operating Expenses (2022 - 2026)
Abivax's (ABVX) quarterly Operating Expenses came in at -$67.4 million in Q1 2026, down 32.96% year-on-year from -$100.5 million in Q1 2025, and down 113.49% quarter-over-quarter from $499.6 million in Q4 2025.
Abivax (ABVX) Operating Expenses (2022 - 2026) Analysis & Trends
Abivax's Operating Expenses history runs 5 years deep, the most recent figure standing at -$67.4 million for Q1 2026.
- On a quarterly basis, Operating Expenses fell 32.96% year-over-year to -$67.4 million in Q1 2026; TTM through Mar 2026 was $281.5 million, a 44.68% increase from a year earlier, with the FY2025 full-year figure at $291.7 million, up 45.36% from the prior year.
- Operating Expenses eased to -$67.4 million in Q1 2026 per ABVX's latest filing, from $499.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $499.6 million in Q4 2025 and bottomed at -$96.7 million in Q3 2025.
- The 5-year median for Operating Expenses is -$49.8 million (2024), against an average of $38.8 million.
- Across the five-year window, Operating Expenses tumbled 90.86% in 2023 and surged 256009642.09% in 2024, its largest moves.
- Year by year, Operating Expenses stood at -$70.81 in 2022, then tumbled by 90.86% to -$135.14 in 2023, then soared by 256009642.09% to $346.0 million in 2024, then surged by 44.4% to $499.6 million in 2025, then slumped by 113.49% to -$67.4 million in 2026.
- Per Business Quant, the three latest ABVX Operating Expenses figures stand at -$67.4 million (Q1 2026), $499.6 million (Q4 2025), and -$96.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | -67.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.40 Mn |
| Dec 31, 2025 | 499.57 Mn |
| Sep 30, 2025 | -96.75 Mn |
| Jun 30, 2025 | -53.87 Mn |
| Mar 31, 2025 | -50.69 Mn |
| Dec 31, 2024 | 345.97 Mn |
| Sep 30, 2024 | -56.57 Mn |
| Jun 30, 2024 | -44.10 Mn |
| Mar 31, 2024 | -49.82 Mn |
| Dec 31, 2023 | -135.14 |
| Dec 31, 2022 | -70.81 |